EUVIMEDEUVIMED entdecken
Crossref

Dual‐[ 18 FMISO + 18 FLT] PET/CT and MRI imaging in glioblastoma

Sadek A Nehmeh, Chang Cui, Rajiv Magge, Theodore H Schwartz, Jazmin Schwartz, Benjamin Liechty, Phelipi Schuck, Stefaan Guhlke, William Calimag, Ramon F Barajas, Dan Kadrmas, Howard Fine und 1 weitere

Medical Physics · 2025

DOI: 10.1002/mp.18124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, 2025. Verfasst von Sadek A Nehmeh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medical College, New York, New York, USA. Hauptthemen laut MEDLINE: Glioblastoma, Magnetic Resonance Imaging, Misonidazole, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Tilzer-Rhodes Center for Glioblastoma at New York-Presbyterian Hospital..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor hypoxia and proliferation are independent predictors of poor prognosis in glioblastoma and WHO grade 4 IDH‐mutant astrocytoma, and are closely linked and can synergistically contribute to local recurrence (LR) and poor overall survival (OS). These two hallmarks can be imaged using FMISO and FLT PET, but only on different days due to the PET intrinsic limitation, which jeopardizes the clinical feasibility and accuracy of multi‐parametric studies.

Purpose

In this study, we assess the feasibility of dual‐[FMISO+FLT]‐PET in a cohort of patients with glioblastoma and WHO grade 4 IDH‐mutant astrocytoma.

Methods

Eight patients underwent 90 min dynamic PET (dynPET) with staggered FMISO/FLT injections followed by two 10 min scans at 120 and 180 min post‐FMISO injection, respectively. The target volume (TV) was delineated on the 180‐min imageset. The FMISO input function (IF) was derived from dynPET images of the carotids using the first 50 min, and then extrapolated to the rest of dynPET using a 3‐exp fit. The IF FLT was deduced by subtracting the IF FMISO from IF FMISO+FLT over the range > 50 min. The FMISO and FLT kinetic rate constants (KRCs) of the TV and cerebellar cortex (reference tissue) were estimated using kinetic modeling (KM) with a parallel dual‐1‐tissue‐2‐compartment model.

Results

Seven out of eight patients with a total of 13 lesions completed the study. All lesions were [FMISO+FLT]‐avid at 180 min post‐FMISO injection with a mean SUVR of 1.72 (range:1.26–3.23). IDH‐mutant WHO grade 4 astrocytomas showed reduced tumor hypoxia. Mean lesion KRCs were K 1‐FMISO = 0.18 mL/cc/min (range:0.042–0.432), k i‐FMISO = 0.011 min −1 (range:0.00–0.039), K 1‐FLT = 0.103 mL/cc/min (range: 0.004–0.357), and K i‐FLT = 0.014 mL/min/g (range: 0.00–0.062). Cerebellar cortex KRCs were K 1‐FMISO = 0.098 mL/cc/min (range:0.055–0.225), k i‐FMISO = 0.008 min −1 (range:0.002–0.014), K 1‐FLT = 0.089 mL/cc/min (range: 0.001–0.299), and K i‐FLT = 0.003 mL/min/g (range:0.00–0.007). Lesion perfusion and hypoxia were inversely correlated ( R = 0.99).

Conclusions

Dual‐[FMISO+FLT]‐PET can provide detailed characterization of tumor microenvironment and interaction of multiple hallmarks that yield radio‐resistance. This can improve the accuracy of image‐guided radiosurgery and radiotherapy, thereby improving clinical outcomes in patients with glioblastoma and IDH‐mutant WHO grade 4 astrocytoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMagnetic Resonance ImagingMisonidazolePositron Emission Tomography Computed TomographyDideoxynucleosidesBrain NeoplasmsHumansMiddle AgedMaleFemaleAdultAged

Stichwörter der Autor:innen

FLTFMISOdual‐tracer PETglioblastoma

Substanzen

MisonidazolefluoromisonidazoleDideoxynucleosidesalovudine

Autor:innen und Institutionen

  • Weill Cornell Medical College, New York, New York, USA.
  • Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Oregon Health & Science University, Portland, USA.
  • Multi-Functional Imaging, South Ogden, USA.

Förderung

  • Tilzer-Rhodes Center for Glioblastoma at New York-Presbyterian Hospital.

Zitieren

APA

Nehmeh, S. A., Cui, C., Magge, R., Schwartz, T. H., Schwartz, J., Liechty, B., Schuck, P., Guhlke, S., Calimag, W., Barajas, R. F., Kadrmas, D., Fine, H., & Ivanidze, J. (2025). Dual‐[ 18 FMISO + 18 FLT] PET/CT and MRI imaging in glioblastoma. Medical Physics. https://doi.org/10.1002/mp.18124

Vancouver

Nehmeh SA, Cui C, Magge R, Schwartz TH, Schwartz J, Liechty B, et al. Dual‐[ 18 FMISO + 18 FLT] PET/CT and MRI imaging in glioblastoma. Medical Physics. 2025. doi:10.1002/mp.18124

BibTeX
@article{Nehmeh2025,
  author = {Nehmeh, Sadek A and Cui, Chang and Magge, Rajiv and Schwartz, Theodore H and Schwartz, Jazmin and Liechty, Benjamin and Schuck, Phelipi and Guhlke, Stefaan and Calimag, William and Barajas, Ramon F and Kadrmas, Dan and Fine, Howard and Ivanidze, Jana},
  title = {Dual‐[ 18 FMISO + 18 FLT] PET/CT and MRI imaging in glioblastoma},
  journal = {Medical Physics},
  year = {2025},
  doi = {10.1002/mp.18124}
}
Kostenlos starten →